Substance Misuse in Pregnancy - NHS Lothian
Substance Misuse in Pregnancy - NHS Lothian
Substance Misuse in Pregnancy - NHS Lothian
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
• poor feed<strong>in</strong>g ability (hungry but difficulty <strong>in</strong> suck<strong>in</strong>g, swallow<strong>in</strong>g and<br />
successfully complet<strong>in</strong>g a feed)<br />
• regurgitation and vomit<strong>in</strong>g<br />
• frequent loose stools or diarrhoea (which cause peri-anal excoriation)<br />
• poor weight ga<strong>in</strong> or weight loss<br />
• repetitive sneez<strong>in</strong>g, yawn<strong>in</strong>g, hiccoughs, nasal stuff<strong>in</strong>ess<br />
• tachypnoea (rapid shallow breath<strong>in</strong>g)<br />
• respiratory depression<br />
• <strong>in</strong>creased pulse and heart rate<br />
• temperature <strong>in</strong>stability, fever (>37.5 C), sweat<strong>in</strong>g and dehydration<br />
• mottl<strong>in</strong>g (discolouration of sk<strong>in</strong>)<br />
• excoriation (sk<strong>in</strong> abrasions) from excessive movement (usually seen<br />
around the buttocks, back of the head, shoulders, and heels)<br />
• seizures (fits)<br />
Seizures occur rarely (<strong>in</strong> approximately 5% of <strong>in</strong>fants) and may manifest<br />
up to 30 days after birth (mean age of onset is 10 days).<br />
The onset, duration and severity of NAS symptoms vary greatly and<br />
depend on many factors, <strong>in</strong>clud<strong>in</strong>g the:<br />
• type of drugs used<br />
• duration of mother’s dependency<br />
• tim<strong>in</strong>g and amount of the mother’s last dose<br />
• metabolism and elim<strong>in</strong>ation of the drug by the <strong>in</strong>fant, as well as the<br />
• gestational age of the <strong>in</strong>fant.<br />
Data on possible dose related effects of methadone are <strong>in</strong>conclusive<br />
(Johnstone 1998). Some studies show no correlation between maternal<br />
methadone dose and the development or severity of NAS. Others have<br />
found a weak positive correlation. Little data exists on the dose related<br />
effects of maternal benzodiazep<strong>in</strong>e use.<br />
Symptoms normally present with<strong>in</strong> the first 24 - 72 hours of birth (<strong>in</strong><br />
approximately 75% of cases). Methadone withdrawal <strong>in</strong> the neonate can<br />
present later than hero<strong>in</strong> withdrawal. Methadone withdrawal symptoms<br />
can also last longer and be more severe (Sparey & Wilk<strong>in</strong>shaw 1999). The<br />
onset of benzodiazep<strong>in</strong>e withdrawal <strong>in</strong> neonates can also be delayed (due<br />
<strong>Substance</strong> <strong>Misuse</strong> <strong>in</strong> <strong>Pregnancy</strong><br />
44